scispace - formally typeset
L

Lars Maegdefessel

Researcher at Technische Universität München

Publications -  185
Citations -  7230

Lars Maegdefessel is an academic researcher from Technische Universität München. The author has contributed to research in topics: Medicine & Inflammation. The author has an hindex of 41, co-authored 144 publications receiving 5098 citations. Previous affiliations of Lars Maegdefessel include Stanford University & Martin Luther University of Halle-Wittenberg.

Papers
More filters
Journal ArticleDOI

MicroRNA-26a Is a Novel Regulator of Vascular Smooth Muscle Cell Function

TL;DR: MicroRNA‐26a represents an important new regulator of SMC biology and a potential therapeutic target in AAA disease, and alters TGF‐β pathway signaling.
Journal ArticleDOI

Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development

TL;DR: Investigating the role of miRs in 2 murine models of experimental AAA suggests that therapeutic manipulation of miR-29b and its target genes holds promise for limiting AAA disease progression and protecting from rupture.
Journal ArticleDOI

MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion

TL;DR: The role of miR-21 is identified as a key modulator of proliferation and apoptosis of vascular wall smooth muscle cells during development of AAA in two established murine models and may offer a new therapeutic pathway that could be targeted to treat AAA in patients.
Journal ArticleDOI

Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death.

TL;DR: This work demonstrates that extracellular histone H4-mediated membrane lysis of smooth muscle cells (SMCs) triggers arterial tissue damage and inflammation, and identifies a form of cell death found at the core of chronic vascular disease that is instigated by leukocytes and can be targeted therapeutically.